Groenhuysen Wilhelmus CM's Form 4 filing
NovoCure Ltd (NVCR) · filed Mar 7, 2023
- Accession no.
- 0001562180-23-002579
- Filed
- Mar 7, 2023
- Trade date
- Mar 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $1.95M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Groenhuysen Wilhelmus CMCIK 0001264783 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 | Ordinary Shares | SSaleDisposed | −3,528 | $76.16 | −$268,692.48 | 231,860 | Direct | |
| Mar 3, 2023 | Ordinary Shares | SSaleDisposed | −1,692 | $76.16 | −$128,862.72 | 230,168 | Direct | |
| Mar 3, 2023 | Ordinary Shares | SSaleDisposed | −20,415 | $76.16 | −$1,554,806.4 | 209,753 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.